It was a pleasure to take part in the Servier x Paris-Saclay Cancer Cluster Annual Event, a key gathering focused on advancing innovation in oncology through public-private partnerships.
Our CEO, Nicolas Wolikow, joined a roundtable at the Servier R&D Institute in Paris-Saclay. The event, co-organized by Servier and the Paris-Saclay Cancer Cluster, brought together key players from the oncology ecosystem. During the roundtable, he shared insights on how biotech startups and pharmaceutical companies can strengthen partnerships to accelerate drug development and bring innovative Cancer therapies to patients faster.
Nicolas Wolikow joined a panel of leading experts, including Julien Elric (Jeito Life Sciences), Emmanuel Gomez (Inatherys), Simon Pico (Hephaistos Pharma), François Lehembre (Servier) and Lucie Mondoulet (PSCC Boost). The session was moderated by Alix Scholher-Dahirel.
This event underscores the importance of collaboration between startups and pharma, fostering a strong ecosystem for oncology innovation in Europe.
Updated: April 7, 2026
